4th Quarter - Termination

EAST END GROUP, LLC for NOVARTIS

Firm
Client
Income
$45,000
Expenses
—
Terminated
Dec 30, 2022

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 17, 2023 $45,000 Replaced
4th Quarter - Termination (this page) Jan 23, 2023 $45,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislation, include the Prescription Drug User Fee Act Reauthorization (PDUFA), Budget Reconciliation other regulatory issues.

LobbyistCovered position, as disclosed
KELLY CHILDRESS LANGE Rep. Mike Rogers, LA; Rep. John Shimkus, LA.
ANDREW HAWKINS Rep. Mike Rogers, Chief of Staff, LD, LA.
DAVID THOMSON MOHLER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General health care coverage and reimbursement for prescription drugs; drug pricing reform, included in Budget Reconciliation other regulatory issues.

LobbyistCovered position, as disclosed
KELLY CHILDRESS LANGE Rep. John Shimkus, LA; Rep. Mike Rogers, Health Policy Advisor
ANDREW HAWKINS Rep. Mike Rogers, LA, Chief of Staff
DAVID THOMSON MOHLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.